The FDA Seeks $22 Million in User Fees for Reinspections

Devices & Diagnostics Letter
KEYWORDS FDA / inspections

Device and drug manufacturers may find themselves coughing up more money to pay proposed FDA user fees that would fund the agency’s reinspections of manufacturing plants that fail initial review.

To View This Article:


Buy This Article Now

Add this article to your cart for $10.00